Management of acute odontogenic pain is accomplished with the use of opioid analgesics, non-steroidal anti-inflammatory agents (NSAIDs), acetaminophen, and, occasionally, cannabis. However, the respiratory depressive effects of opioid analgesics, the anti-inflammatory effects of NSAIDs, the potential hepatoxic effects of acetaminophen and the immunosuppressive effects of cannabis might actually worsen the progression of, and the comorbidities associated with COVID-19 infection. This webinar will explore the rationale for the continued use of these agents in the management of odontogenic pain in patients who are at risk for or who have been infected with COVID-19.
· Describe the pharmacology and mechanism of action of opioid analgesics, NSAIDs and acetaminophen.
· Describe the pharmacology and proposed mechanism of action of cannabis in the management of odontogenic pain.
· Identify the rationale for and the potential risks of using these agents for the management of odontogenic pain with regard to COVID-19 infection.
Since the intellectual property contained in this online course is made available on-demand immediately after purchase, no refunds will be issued for this course after purchase.This course is available for credit until 3/1/22.